2025-17583Notice

Medical Firm Eyes Controlled Drug Import Approval

Published Date: 9/12/2025

Notice

Summary

Fresenius Kabi USA, LLC wants to get official approval to import certain controlled substances. This means they’ll be allowed to bring in specific drugs that need special handling. If approved, it could affect drug availability and timing, but no cost changes are mentioned yet.

Analyzed Economic Effects

1 provisions identified: 0 benefits, 0 costs, 1 mixed.

Importer Application Could Change Drug Supply

Fresenius Kabi USA, LLC has applied to be registered as an importer of certain controlled substances. If approved, they would be allowed to bring in specific drugs that need special handling, which could affect the availability and timing of those drugs; the notice does not mention any changes to prices or costs.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
9/12/2025
10/14/2025

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in